{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:22:33Z","timestamp":1794640953895,"version":"4.9.1"},"reference-count":44,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Parkinson\u2019s Disease"],"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:p>\n                    <jats:italic toggle=\"yes\">Mucuna pruriens<\/jats:italic>\n                    (MP), a leguminous plant naturally rich in levodopa, has regained attention as both a traditional remedy and a potential therapeutic option for Parkinson's disease (PD). Its appeal is shaped by contrasting contexts: in low- and middle-income countries (LMICs), MP may represent a cost-effective, locally cultivable alternative where access to levodopa-based medications is severely limited; in high-income countries, patients are often drawn to its \u201cnatural\u201d label, perceiving it as safer or more holistic than synthetic drugs. Evidence from randomised and open-label clinical trials demonstrates that properly processed MP preparations provide symptomatic benefits comparable to commercial levodopa, though long-term safety data are still scarce. However, despite its natural origin, MP is a potent dopaminergic therapy requiring the same caution as commercially available levodopa-based medications. Overuse and unsupervised self-medication have been associated with dyskinesia, dopamine dysregulation syndrome, and psychiatric complications, while cases of toxicity from improper seed preparation underscore its risks. In our view, a balanced perspective is essential: while MP holds promise as a sustainable therapeutic option in LMICs, its use should remain restricted to clinical trials or neurologist-led protocols until more robust evidence of long-term safety and efficacy emerges.\n                  <\/jats:p>","DOI":"10.1177\/1877718x261442075","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T12:28:17Z","timestamp":1777465697000},"page":"788-794","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["\u201c\n                    <i>To Bean or Not to Bean<\/i>\n                    \u201d: Therein lie the hype and the hope. Advice to people with Parkinson in my clinic about\n                    <i>Mucuna pruriens<\/i>"],"prefix":"10.1177","volume":"16","author":[{"given":"Roberto","family":"Cilia","sequence":"first","affiliation":[{"name":"Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Katzenschlager","sequence":"additional","affiliation":[{"name":"Department of Neurology and Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Klinik Donaustadt, Vienna, Austria"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2016.04.001"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.2003.028761"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2020.03.002"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2024.106983"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870050112"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.25420"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30195-4"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.28669"},{"key":"e_1_3_2_10_2","volume-title":"Improving access to medicines for neurological disorders","author":"World Health Organization","year":"2024","unstructured":"World Health Organization (2024) Improving access to medicines for neurological disorders. Geneva: WHO. https:\/\/www.who.int\/publications\/i\/item\/9789240097377. Accessed May 5, 2025"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/1877718X251383721"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00218-X"},{"key":"e_1_3_2_13_2","article-title":"Delivery of allied health therapies to people with Parkinson\u2019s disease in Africa","volume":"14","author":"Cilia R","year":"2023","unstructured":"Cilia R, Dekker MCJ, Cubo E, et al. Delivery of allied health therapies to people with Parkinson\u2019s disease in Africa. J Parkinsons Dis 2023; 14: S227\u2013S239.","journal-title":"J Parkinsons Dis"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080952"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12294"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/mdc3.12682"},{"key":"e_1_3_2_17_2","first-page":"34","article-title":"Availability of Parkinson\u2019s disease medicines in Ghana: a national survey [abstract]","author":"Cham M","year":"2019","unstructured":"Cham M, Sefah I, Oppon K, et al. Availability of Parkinson\u2019s disease medicines in Ghana: a national survey [abstract]. Mov Disord 2019: 34. https:\/\/www.mdsabstracts.org\/abstract\/availabilityof-parkinsons-disease-medicines-in-ghana-a-nationalsurvey\/. accessed May 5, 2025.","journal-title":"Mov Disord"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21898"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1155\/padi\/1319419"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000004175"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2018.01.014"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.3171-23"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-025-02914-2"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1089\/acm.1995.1.249"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(00)00329-4"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-018-0067-z"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000152880.77812.5B"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1809983"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu195"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu212"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-181500"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.parkreldis.2020.06.014"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.14802\/jmd.24067"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(90)92603-F"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.wem.2021.10.004"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1089\/acm.2017.0054"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2022.2184"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchemneu.2022.102115"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.3390\/cimb46080545"},{"key":"e_1_3_2_40_2","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70540"},{"key":"e_1_3_2_41_2","doi-asserted-by":"publisher","DOI":"10.3390\/neurolint16060112"},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27103131"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1515\/1553-3840.1520"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/s12010-025-05227-y"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1002\/ptr.7987"}],"container-title":["Journal of Parkinson\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261442075","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1877718X261442075","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1877718X261442075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:08:38Z","timestamp":1794640118000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/1877718X261442075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":44,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1177\/1877718X261442075"],"URL":"https:\/\/doi.org\/10.1177\/1877718x261442075","relation":{},"ISSN":["1877-7171","1877-718X"],"issn-type":[{"value":"1877-7171","type":"print"},{"value":"1877-718X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]}}}